CDX2 and neuroendocrine carcinoma: Negative results were obtained for cytokeratin 20, CDX2, CD56, S100, and neuroendocrine markers such as synaptophysin, which excluded other tumor types, including neuroendocrine carcinoma and adenocarcinoma (Figure 1G,H).